Polivy(polatuzumab vedotin-piiq)

[Brief introduction of polivy (Polatzumab Vedotin-piiq)]

Polivy is a kind of combined drug. Polatuzumab vedotin (hereinafter referred to as Pola) is an Antibody-Drug Conjugate (ADC) of CD79b, which consists of three parts: Antibody (anti-CD79b antibody); Linker (cleavable protease linking peptide); Cytotoxin (MMAE). Together, these three items constitute an ADC drug.

【 indications of Polivy(polatuzumab vedotin-piiq) 】

This product is suitable for the treatment of B-cell lymphoma with R-CHOP.

[Polish (Polatzumab Vedotin-PIIQ) specification]

This product is an injection with the specification of 140mg/ unit.